Cynosure IncMost RecentFund ManagersBaupost Group Slightly Reduced Its Stake in Syneron MedicalThe Baupost Group lowered its position in Syneron Medical (ELOS) during 4Q14. The position accounted for a minor 0.4% of the total portfolio in 4Q14.
Fund ManagersBaupost Group Slightly Reduced Its Stake in Syneron MedicalThe Baupost Group lowered its position in Syneron Medical (ELOS) during 4Q14. The position accounted for a minor 0.4% of the total portfolio in 4Q14.
